Key facts
- This page summarizes Robert J. Rivet's Form 4 filing for CURTISS WRIGHT CORP (CW).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Jan 2025, 16:20.
Robert J. Rivet - 21 Jan 2025 Form 4 Insider Report for CURTISS WRIGHT CORP (CW)
- Reporting relationship
- Director
- Issuer ticker
- CW
- Reported as of
- 21 Jan 2025
- Net transaction value
- +$359,215
- SEC form
- 4
- Accepted by SEC
- 21 Jan 2025, 16:20:28 UTC
- Prior SEC filing
- 20 Feb 2024
- Next SEC filing
- 11 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- George P. McDonald by Power of Attorney for Robert J. Rivet
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Robert J. Rivet filed Form 4 for CURTISS WRIGHT CORP (CW) on 21 Jan 2025.
Change
- Previous filing in this sequence was filed on 20 Feb 2024.
- Current net transaction value: +$359,215.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CW
transaction
Common Stock
Award
- Transaction value
- $359,215
- Shares
- +979
- Change %
- +6.7%
- Price
- $366.92
- Shares after
- 15,568
- Date
- 21 Jan 2025
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer their compensation and/or receive their annual retainer and meeting fees in the form of stock at a later date.
Footnote F2
Number of shares calculated based on the value of the award divided by the closing price of $139.62 for Issuer's common stock as reported by the New York Stock Exchange on February 16, 2022, the date the Board initially approved the award.
Footnote F3
Price is based on the closing market price for the securities on the New York Stock Exchange as of January 20, 2025. The date recipient elected to receive his shares.